The Oncosearch | Oncotarget

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Correction

Steven A. Greenberg

Published Mar 20, 2026 · Vol. 17, No. 1 · pp. 57-58

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Valeriy Domenyuk, Kasey Benson, Peggy Carter, Daniel Magee, Jian Zhang, Nitin Bhardwaj, Hongseok Tae, James Wacker, Foram Rathi, Siobhan Miick, Aastha Kohli, Joshua Carroll, Lori Cuyugan, Evelyn Perez, Wayeesha Zhang, John Collins, Patrick Kennedy, Jeremy Ellis, Adam Stark, Andrey Loskutov, Brittany Cuttone, Blake Taylor, Rebecca Feldman, Jeff Swenson, David Bryant, Robert Hahn-Lowry, Raunaq Kaushal, Jennifer R. Ribeiro, Jim Abraham, Milan Radovich, George W. Sledge, Matthew Oberley, David Spetzler

Published Aug 6, 2025 · Vol. 16, No. 1 · pp. 642-659

Keywords: companion diagnostic, molecular profiling, solid tumors, precision oncology, next-generation sequencing

Comprehensive genomic profiling of over 10,000 advanced solid tumors Research Paper

Jean-Paul De La O, Jess R. Hoag, Angela K. Deem, Min Wang, Arthur Starodynov, Sameer S. Udhane, Janine R. LoBello, Nishitha Therala, David W. Hall, Gargi D. Basu, Frederick L. Baehner

Published Jul 19, 2025 · Vol. 16, No. 1 · pp. 587-603

Keywords: solid tumors, comprehensive genomic profiling, matched therapy, gene fusions, limit of detection

Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights Research Paper

Cleto Dantas Nogueira, Samuel Frota, Huylmer Lucena Chaves, Juliana Cordeiro de Sousa, Guilherme de Sousa Veloso, Francisco Jonathan dos Santos Araujo, Gabriel Barbosa Silva, Samuel Silva Ferreira, Marclesson Santos Alves, Fabio Nasser, Ezequiel Rangel, Francisco Martins Neto, Iusta Caminha, Ellen Nascimento, Fabio Tavora

Published May 31, 2025 · Vol. 16, No. 1 · pp. 467-479

Keywords: HER2 mutation, NSCLC, lung cancer, targeted therapy, genomic profiling

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Jinah Kim, Liam Il-Young Chung, Horyun Choi, Yoonhee Choi, Maria Jose Aguilera Chuchuca, Youjin Oh, Young Kwang Chae

Published May 21, 2025 · Vol. 16, No. 1 · pp. 411-418

Keywords: amivantamab, monotherapy, rare EGFR mutation, NSCLC, leptomeningeal disease

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis Research Paper

Nawar Al Nasrallah, Bowa Lee, Benjamin M. Wiese, Marie N. Karam, Elizabeth A. Mickler, Huaxin Zhou, Nicki Paolelli, Robert S. Stearman, Mark W. Geraci, Catherine R. Sears

Published May 9, 2025 · Vol. 16, No. 1 · pp. 396-409

Keywords: DNA repair, DNA damage, lung adenocarcinoma, squamous cell carcinoma, Xeroderma Pigmentosum Group C (XPC)

Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report Case Report

Jenny L. Wu, Wade T. Iams

Published Jan 16, 2025 · Vol. 16, No. 1 · pp. 39-42

Keywords: ROS1 rearrangement, RET rearrangement, non-small cell lung cancer, targeted therapy, case report

Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Research Paper

Steven A. Greenberg

Published Jan 7, 2025 · Vol. 16, No. 1 · pp. 1-8

Keywords: immunotherapy, KLRG1

Targeting the multifaceted BRAF in cancer: New directions Research Perspective

Eamon Toye, Alexander Chehrazi-Raffle, Justin Hwang, Emmanuel S. Antonarakis

Published Jul 10, 2024 · Vol. 15, No. 1 · pp. 486-492

Keywords: BRAF, MAPK, pan-cancer, precision oncology, genomics

Retraction: Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1 Retraction

Cheng-Cao Sun, Shu-Jun Li, De-Jia Li

Published Jul 6, 2024

From osimertinib to preemptive combinations Research Perspective

Mikhail V. Blagosklonny

Published Mar 14, 2024 · Vol. 15, No. 1 · pp. 232-237

Keywords: lung cancer, NSCLC, EGFR, resistance, afatinib, gefitinib, capmatinib

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper

Scott Strum, Mark Vincent, Meghan Gipson, Eric McArthur, Daniel Breadner

Published Feb 28, 2024 · Vol. 15, No. 1 · pp. 381-388

Keywords: tumor marker, biomarker, lung cancer, NSCLC, translational research

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Shreya Bhatia, Manuel G. Cortez, Spencer Lessans, Wade T. Iams

Published Jan 5, 2024 · Vol. 15, No. 1 · pp. 27-30

Keywords: EGFR mutation, leptomeningeal disease, non-small cell lung cancer, osimertinib

Addendum: Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Addendum

Carolina Sciortino, Valentina Viglialoro, Massimo Nucci, Mariam Grazia Polito, Enrico Cortesi, Alain Gelibter, Paola Gazzaniga, Chiara Nicolazzo, Marco Siringo, Salvatore Caponnetto

Published Sep 6, 2023

Addendum: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Addendum

Hazem I. Assi, Maroun Bou Zerdan, Mohammad Hodroj, Makram Khoury, Nour Sabiha Naji, Ghid Amhaz, Reine Abou Zeidane, Fadi El Karak

Published Aug 30, 2023

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Research Paper

Hazem I. Assi, Maroun Bou Zerdan, Mohammad Hodroj, Makram Khoury, Nour Sabiha Naji, Ghid Amhaz, Reine Abou Zeidane, Fadi El Karak

Published May 17, 2023 · Vol. 14, No. 1 · pp. 517-525

Keywords: chemotherapy, immunotherapy, non-small cell lung cancer

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Reyes Bernabé-Caro, Pilar Garrido, Rosario García-Campelo, Ramón Palmero, Ángel Artal, Cristina Bayona, Delvys Rodríguez-Abreu, Marta López-Brea, Alfredo Paredes, David Vicente, José Miguel Sánchez Torres, Margarita Majem, Pilar Diz, Rocío Gordo, Margarita Coca, Javier de Castro

Published Jun 7, 2022 · Vol. 13, No. 1 · pp. 812-827

Keywords: ALK-positive NSCLC, ALK inhibitor, crizotinib, alectinib, unselected patient

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Pooja Gulhane, Prajakta Nimsarkar, Komal Kharat, Shailza Singh

Published May 7, 2022 · Vol. 13, No. 1 · pp. 725-746

Keywords: non-small cell lung cancer, miRNAs, miR-520c-3p, PI3K/AKT signaling pathway, therapeutic targeting

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Research Paper

Carolina Sciortino, Valentina Viglialoro, Massimo Nucci, Mariam Grazia Polito, Enrico Cortesi, Alain Gelibter, Paola Gazzaniga, Chiara Nicolazzo, Marco Siringo, Salvatore Caponnetto

Published Apr 29, 2022 · Vol. 13, No. 1 · pp. 686-693

Keywords: NSCLC, immunotherapy, KRAS G12C mutation, liquid biopsy

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Correction

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Comprehensive genomic profiling of over 10,000 advanced solid tumors Research Paper

Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights Research Paper

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis Research Paper

Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report Case Report

Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Research Paper

Targeting the multifaceted BRAF in cancer: New directions Research Perspective

Retraction: Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1 Retraction

From osimertinib to preemptive combinations Research Perspective

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Addendum: Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Addendum

Addendum: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Addendum

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Correction

Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper

Comprehensive genomic profiling of over 10,000 advanced solid tumors Research Paper

Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights Research Paper

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib Research Paper

Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis Research Paper

Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report Case Report

Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells Research Paper

Targeting the multifaceted BRAF in cancer: New directions Research Perspective

Retraction: Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1 Retraction

From osimertinib to preemptive combinations Research Perspective

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Addendum: Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Addendum

Addendum: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Addendum

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC) Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study Research Paper

Clinical and analytical validation of MI Cancer Seek^®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay Research Paper